June 9, 2020 -- Integrity Bio announced the validation of its second fill/finish manufacturing line in Thousand Oaks, CA. The plant expansion more than doubles the company's manufacturing capacity.
Integrity Bio provides formulation development, good manufacturing practices fill finish services, and drug delivery technologies to support the biotechnology and pharmaceutical industries.
The expanded manufacturing capacity will help the company meet growing demands and prioritize COVID-19 projects, according to Chief Executive Officer Michael Reilly. The new line will allow the company to fill over 20,000 liquid vials in a single batch.